Analysis of Correlation between Bone Marrow Vascular Endothelial Growth Factor per Platelet Count and Blast Percentage in Hematologic Malignancies

被引:0
|
作者
Cho, Chi-Hyun [1 ]
机构
[1] Korea Univ, Coll Med, Dept Lab Med, Ansan Hosp, 123 Jeokgeum Ro, Ansan 15355, Gyeonggi Do, South Korea
来源
基金
新加坡国家研究基金会;
关键词
BM VEGF per platelet count; BM blast %; Hematologic; Malignancy; Bone marrow; PROGNOSTIC-SIGNIFICANCE; CANCER; VEGF; SUPERNATANT; EXPRESSION; RECEPTOR;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objective. Bone marrow (BM) samples reflective of the BM condition are more suitable than peripheral blood samples for the measurement of vascular endothelial growth factor (VEGF) levels in relation to hematologic malignancy. However, BM VEGF levels require calibration, with respect to the platelet count, to eliminate any influence of VEGF released from platelets during sample processing. This parameter is termed the BM VEGF per platelet count. Our aim was to measure BM VEGF per platelet count of patients diagnosed with hematologic malignancy and to analyze its association with several hematological parameters, including BM blast percentages. We also compared the BM VEGF per platelet count and BM blast percentage between the disease and control groups. Methods. BM plasma samples were collected from 73 patients classified into myeloproliferative neoplasm, acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), plasma cell neoplasm (PCN), and control groups. Luminex assays were used to quantify BM VEGF levels. BM cellularity and cell percentage were assessed using BM biopsy and aspiration slides, respectively. Data on hematological parameters were collected from medical records. Single and multiple regression analyses were performed to analyze the relationships between different parameters. Intergroup comparisons were performed using the Kruskal-Wallis H-test. Results. Independent factors associated with BM VEGF per platelet count included BM blast percentage (%), BM band neutrophil %, BM neutrophil %, and BM cellularity. Multiple regression analyses using the four factors generated the following model (adjusted R-2=0.290): BM VEGF per platelet count (x10(-6) pg)=1.488+0.059xBM blast (%). BM VEGF per platelet count was the highest in the AML group (n=13) and lowest in the control group (n=14). Similarly, BM blast % was the highest in the AML group. Compared to that in the PCN group (n=11), the BM blast % in the MDS group (n=12) was higher. Conclusion. BM VEGF per platelet count was related to BM blast %, and both parameters showed similar intergroup patterns, indicating an association.
引用
收藏
页码:469 / 475
页数:7
相关论文
共 50 条
  • [1] Targeting the vascular endothelial growth factor in hematologic malignancies
    Paesler, Julian
    Gehrke, Iris
    Poll-Wolbeck, Simon Jonas
    Kreuzer, Karl-Anton
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2012, 89 (05) : 373 - 384
  • [2] Serum vascular endothelial growth factor per platelet count in patients with binary atresia
    Chongsrisawat, Voranush
    Vejchapipat, Paisarn
    Poovorawan, Yong
    ASIAN BIOMEDICINE, 2010, 4 (02) : 223 - 229
  • [3] Bone marrow vascular endothelial growth factor level per platelet count might be a significant predictor for the treatment outcomes of patients with diffuse large B-cell lymphomas
    Kim, Jung Sun
    Gang, Ga Won
    Lee, Se Ryun
    Sung, Hwa Jung
    Park, Young
    Kim, Dae Sik
    Choi, Chul Won
    Kim, Byung Soo
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (10) : 914 - 920
  • [4] Vascular endothelial growth factor signaling pathway as an emerging target in hematologic malignancies
    List, AF
    ONCOLOGIST, 2001, 6 : 24 - 31
  • [5] Serum vascular endothelial growth factor per platelet count in hepatocellular carcinoma: Correlations with clinical parameters and survival
    Kim, SJ
    Choi, IK
    Park, KH
    Yoon, SY
    Oh, SC
    Seo, JH
    Choi, CW
    Kim, BS
    Shin, SW
    Kim, YH
    Kim, JS
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 34 (04) : 184 - 190
  • [6] Prognostic Significance of Serum Vascular Endothelial Growth Factor Per Platelet Count in Unresectable Advanced Gastric Cancer Patients
    Seo, Hee Yeon
    Park, Joong Min
    Park, Kyong Hwa
    Kim, Seok Jin
    Oh, Sang Cheul
    Kim, Byung Soo
    Kim, Yeul Hong
    Kim, Jun Suk
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (12) : 1147 - 1153
  • [7] Analysis of neutrophil gelatinase-associated lipocalin, vascular endothelial growth factor, and soluble receptor for advanced glycation end-products in bone marrow supernatant in hematologic malignancies
    Cho, Chi-Hyun
    Cha, Jaehyung
    CLINICAL BIOCHEMISTRY, 2020, 80 : 19 - 24
  • [8] Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: Clinical evidence of platelet scavenging?
    George, ML
    Eccles, SA
    Tutton, MG
    Abulafi, AM
    Swift, RI
    CLINICAL CANCER RESEARCH, 2000, 6 (08) : 3147 - 3152
  • [9] PLATELET-ACTIVATING-FACTOR CONCENTRATIONS IN BONE-MARROW OF PATIENTS WITH LYMPHOID AND NONLYMPHOID HEMATOLOGIC MALIGNANCIES
    DENIZOT, Y
    TRIMOREAU, F
    DUPUIS, F
    VERGER, C
    PRALORAN, V
    LEUKEMIA, 1995, 9 (11) : 1982 - 1983
  • [10] The vascular endothelial growth factor (VEGF) signaling pathway: A therapeutic target in patients with hematologic malignancies
    Giles, FJ
    ONCOLOGIST, 2001, 6 : 32 - 39